tiprankstipranks
Psychemedics Corp. (PMD)
NASDAQ:PMD
US Market

Psychemedics (PMD) Stock Price & Analysis

109 Followers

PMD Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.06 - $5.15
Previous Close$2.25
Volume753.00
Average Volume (3M)6.22K
Market Cap
$13.06M
Enterprise Value$13.40M
Total Cash (Recent Filing)$1.96M
Total Debt (Recent Filing)$2.30M
Price to Earnings (P/E)
Beta0.19
Aug 06, 2024
EPS EstimateN/A
Dividend Yield3.11%
Share Statistics
EPS (TTM)-0.77
Shares Outstanding5,805,611
10 Day Avg. Volume4,447
30 Day Avg. Volume6,221
Standard Deviation0.11
R-Squared0.10
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)6.88
Price to Sales (P/S)0.59
Price to Cash Flow (P/CF)4.90
P/FCF Ratio5.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.61
Enterprise Value/Gross Profit1.59
Enterprise Value/Ebitda50.94
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

25.33%9.16%13.18%52.34%
25.33% Insiders
13.18% Other Institutional Investors
52.34% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

PMD FAQ

What was Psychemedics Corp.’s price range in the past 12 months?
Psychemedics Corp. lowest stock price was $2.06 and its highest was $5.15 in the past 12 months.
    What is Psychemedics Corp.’s market cap?
    Currently, no data Available
    When is Psychemedics Corp.’s upcoming earnings report date?
    Psychemedics Corp.’s upcoming earnings report date is Aug 06, 2024 which is in 50 days.
      How were Psychemedics Corp.’s earnings last quarter?
      Psychemedics Corp. released its earnings results on May 14, 2024. The company reported -$0.118 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.118.
        Is Psychemedics Corp. overvalued?
        According to Wall Street analysts Psychemedics Corp.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Psychemedics Corp. pay dividends?
          Psychemedics Corp. pays a Thriceyearly dividend of $0.07 which represents an annual dividend yield of 3.11%. See more information on Psychemedics Corp. dividends here
            What is Psychemedics Corp.’s EPS estimate?
            Psychemedics Corp.’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Psychemedics Corp. have?
            Psychemedics Corp. has 5,805,611 shares outstanding.
              What happened to Psychemedics Corp.’s price movement after its last earnings report?
              Psychemedics Corp. reported an EPS of -$0.118 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.019%.
                Which hedge fund is a major shareholder of Psychemedics Corp.?
                Currently, no hedge funds are holding shares in PMD
                ---

                Psychemedics Stock Smart Score

                N/A
                Not Ranked
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Negative
                20 days / 200 days
                Momentum
                -51.71%
                12-Months-Change

                Fundamentals

                Return on Equity
                -54.21%
                Trailing 12-Months
                Asset Growth
                -37.72%
                Trailing 12-Months

                Company Description

                Psychemedics Corp.

                Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. It specializes in a five panel drug testing process for cocaine, opioids, Phenyclidine, amphetamines, and marijuana. It offers workplace, school, and personal drug testing services. The company was founded by Werner Baumgartner and Annette Baumgartner on September 24, 1986 and is headquartered in Acton, MA.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Alcon
                Charles River Labs
                Illumina
                Laboratory
                Popular Stocks
                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis